(VCEB) ESG U.S. Corporate Bond - Overview
Etf: Corporate, Bonds, Esg, Investment-Grade
Dividends
| Dividend Yield | 5.00% |
| Yield on Cost 5y | 4.63% |
| Yield CAGR 5y | 23.72% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 3.11% |
| Relative Tail Risk | 1.41% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.52 |
| Alpha | 1.31 |
| Character TTM | |
|---|---|
| Beta | 0.091 |
| Beta Downside | 0.050 |
| Drawdowns 3y | |
|---|---|
| Max DD | 6.55% |
| CAGR/Max DD | 0.84 |
Description: VCEB ESG U.S. Corporate Bond January 25, 2026
The Vanguard ESG U.S. Corporate Bond ETF (VCEB) tracks an index that excludes bonds with maturities under one year and issue sizes below $750 million, applying an independent ESG screen before Vanguard conducts a sampling selection; by design, at least 80 % of the fund’s assets must be allocated to bonds that meet these criteria.
As of the latest reporting (Q4 2025), VCEB’s weighted-average maturity is approximately 6.2 years, its effective duration sits near 5.4, and the portfolio’s average credit rating is A- (S&P), reflecting a focus on investment-grade issuers. ESG-filtered corporate issuance has grown 18 % year-over-year, driven largely by the technology and health-care sectors, which together account for roughly 42 % of the fund’s holdings. The fund’s yield to maturity is currently 4.1 %, modestly above the broader U.S. investment-grade corporate bond index, a spread that reflects both the ESG premium and the higher concentration in longer-dated securities.
For a deeper dive into how VCEB’s ESG weighting compares to sector-specific risk factors, consider exploring ValueRay’s analytical tools.
What is the price of VCEB shares?
Over the past week, the price has changed by +0.29%, over one month by +0.35%, over three months by +0.80% and over the past year by +6.70%.
Is VCEB a buy, sell or hold?
What are the forecasts/targets for the VCEB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 68.4 | 7.4% |
VCEB Fundamental Data Overview February 05, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.04b USD (1.04b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.04b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.04b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.25% (E(1.04b)/V(1.04b) * Re(6.25%) + (debt-free company))
Discount Rate = 6.25% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)